Tofacitinib: Big Cutaneous Sarcoidosis Response in Small Study Tofacitinib: Big Cutaneous Sarcoidosis Response in Small Study

"Not only did patients get better, but they were in many cases able to come off their baseline immunosuppressive regimen."Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Dermatology News Source Type: news